This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Yutaka Obuchi: Innovator in Cancer Treatment
Introduction
Yutaka Obuchi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for malignant tumors. His innovative work has the potential to impact cancer therapy positively.
Latest Patents
Yutaka Obuchi holds a patent for a compound known as 5-methyl-6-phenyl-4,5-dihydro-2H-pyridazin-3-one derivative. This invention provides an agent for treating malignant tumors, comprising a compound of formula (1). His patent represents a step forward in the search for effective cancer treatments.
Career Highlights
Obuchi is associated with Otsuka Pharmaceutical Company, Limited, where he has been able to apply his expertise in drug development. His work at Otsuka has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Takahiro Katoh and Masatoshi Iida. Their combined efforts contribute to the advancement of pharmaceutical innovations.
Conclusion
Yutaka Obuchi's contributions to cancer treatment through his patented invention highlight his role as an important figure in the pharmaceutical industry. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile